Tenon Medical, Inc. (TNON) Insider Trading Activity

NASDAQ$0.8689
Market Cap
$7.48M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
832 of 881
Rank in Industry
105 of 113

TNON Insider Trading Activity

TNON Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
3
100
Sells
$0
0
0

Related Transactions

FOSTER STEVEN MCEO and President
1
$0
0
$0
$0
Geist Wyatt D.Chief Innovation Officer
1
$0
0
$0
$0
Grawey Nathaniel A.Chief Commercial Officer
1
$0
0
$0
$0

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Insider Activity of Tenon Medical, Inc.

Over the last 12 months, insiders at Tenon Medical, Inc. have bought $0 and sold $0 worth of Tenon Medical, Inc. stock.

On average, over the past 5 years, insiders at Tenon Medical, Inc. have bought $6,825 and sold $116,904 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 101,167 shares for transaction amount of $0 was made by Grawey Nathaniel A. (Chief Commercial Officer) on 2025‑11‑14.

List of Insider Buy and Sell Transactions, Tenon Medical, Inc.

2025-11-14PurchaseGrawey Nathaniel A.Chief Commercial Officer
101,167
$0
$0
-19.11%
2025-11-14PurchaseGeist Wyatt D.Chief Innovation Officer
19,455
$0
$0
-19.11%
2025-11-14PurchaseFOSTER STEVEN MCEO and President
19,455
$0
$0
-19.11%
2023-06-14PurchaseVAN DICK STEVEN MChief Financial Officer
50,000
0.4158%
$0.27
$13,650
-48.97%
2023-05-23SaleGINN RICHARDChief Technology Officer
64,990
0.5735%
$1.26
$81,887
-87.80%
2023-05-23SaleFOSTER STEVEN MCEO and President
27,791
0.2453%
$1.26
$35,017
-87.80%
Total: 6
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Grawey Nathaniel A.Chief Commercial Officer
239281
2.7807%
$207,911.2610
Geist Wyatt D.Chief Innovation Officer
157569
1.8311%
$136,911.7010
FOSTER STEVEN MCEO and President
22878
0.2659%
$19,878.6911
VAN DICK STEVEN MChief Financial Officer
100416
1.1669%
$87,251.4610
<0.0001%
GINN RICHARDChief Technology Officer
85318
0.9915%
$74,132.8101
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,105,104
34
-11.40%
$328.12M
$58,432,429
19
7.16%
$387.96M
$5,183,021
19
-4.75%
$72.08M
$783,570
13
7.19%
$156.19M
$14,564
7
27.01%
$7.78M
$165,149
7
-44.78%
$11.27M
$24,971
6
-37.72%
$39.59M
$12,684,208
6
17.63%
$18.75M
$330,888
5
7.30%
$176,582.00
$21,637
4
-55.86%
$2.19M
Tenon Medical, Inc.
(TNON)
$13,650
1
-48.97%
$7.48M
$41,634
1
-5.20%
$162.3M
$1,499,999
1
129.39%
$190.35M
$19,977
1
10.97%
$379.32M

TNON Institutional Investors: Active Positions

Increased Positions9+64.29%236,868+89.47%
Decreased Positions4-28.57%8,088-3.06%
New Positions5New212,266New
Sold Out Positions<1Sold Out80Sold Out
Total Postitions19+35.71%493,516+86.42%

TNON Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$113.001.06%116,343+116,343New2025-09-30
Geode Capital Management, Llc$48.000.45%49,503+28,856+139.76%2025-09-30
Sbi Securities Co., Ltd.$39.000.36%39,722-13-0.03%2025-09-30
Xtx Topco Ltd$23.000.22%23,933+311+1.32%2025-09-30
Citadel Advisors Llc$18.000.17%18,957+18,957New2025-09-30
Spectrum Asset Management, Inc. (Nb/Ca)$10.000.1%10,650-15,000-58.48%2025-09-30
Tower Research Capital Llc (Trc)$3.000.03%3,023+471+18.46%2025-09-30
Ubs Group Ag$2.000.02%2,176-9,617-81.55%2025-09-30
Morgan Stanley$0<0.01%18800%2025-09-30
Root Financial Partners, Llc$0<0.01%80+80New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.